American journal of infection control · 2025
Impact of empowerment of onco-hematological patients on the incidence of catheter-related bloodstream infections.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Reghini Rodrigo, França E Silva Ivan Leonardo Avelino, Costa Silvia Figueiredo, Guimarães Thaís
Аннотация
BACKGROUND: Patients with hematologic malignancies and hematopoietic stem cell transplant recipients (HSCT) are at high risk of central venous catheter-related bloodstream infections (CLABSI). Global actions have encouraged patient empowerment as a strategy to reduce these infections. We aim to evaluate the impact of patient empowerment in reducing the incidence density (ID) of CLABSI.
METHODS: Prospective, pre- and post-intervention, quantitative study of development, validation and application of an instrument to assess good practices in CVC handling, consisting of 6 questions and answers by hospitalized patients who had a CVC in 2 oncological units.
RESULTS: Fifty-three patients were enrolled, totaling 1,290 evaluations. In the postintervention period, a significant increase (P < .001) was observed in 3 practices: hand hygiene after handling the CVC (92.1% vs 98.8%), salinization with pulsatile movements after administering medications and collecting laboratory tests (86.8% vs 96.7%) and daily CVC assessment (97.4% vs 99.8%). The ID of CLABSI decreased in the HSCT unit (4.4 vs 0 CLABSI/1,000 CVC-days), though without statistical significance (P = .066).
DISCUSSION: Increased adherence to good practices highlights the potential of patient involvement as a complementary strategy for CLABSI prevention.
CONCLUSIONS: Actions aimed at patient participation can contribute to improving processes and reducing the ID of CLABSI.
METHODS: Prospective, pre- and post-intervention, quantitative study of development, validation and application of an instrument to assess good practices in CVC handling, consisting of 6 questions and answers by hospitalized patients who had a CVC in 2 oncological units.
RESULTS: Fifty-three patients were enrolled, totaling 1,290 evaluations. In the postintervention period, a significant increase (P < .001) was observed in 3 practices: hand hygiene after handling the CVC (92.1% vs 98.8%), salinization with pulsatile movements after administering medications and collecting laboratory tests (86.8% vs 96.7%) and daily CVC assessment (97.4% vs 99.8%). The ID of CLABSI decreased in the HSCT unit (4.4 vs 0 CLABSI/1,000 CVC-days), though without statistical significance (P = .066).
DISCUSSION: Increased adherence to good practices highlights the potential of patient involvement as a complementary strategy for CLABSI prevention.
CONCLUSIONS: Actions aimed at patient participation can contribute to improving processes and reducing the ID of CLABSI.